Progression of liver cirrhosis to HCC: An application of hidden Markov model

BMC Medical Research Methodology

Volumn 11, Issue , 2011, Pages

  Bartolomeo, Nicola ^a   Trerotoli, Paolo ^a   Serio, Gabriella ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ALCOHOLISM; ARTICLE; COMORBIDITY; DISEASE COURSE; HEALTH SERVICE; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; MORTALITY; PATHOLOGY; PROBABILITY; SEX DIFFERENCE;

AGE FACTORS; ALCOHOLISM; CARCINOMA, HEPATOCELLULAR; COMORBIDITY; DISEASE PROGRESSION; HEALTH SERVICES; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MARKOV CHAINS; SEX FACTORS;

EID: 79953263053     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-11-38     Document Type: Article

References (40)

1. Hepatitis C and hepatocellular carcinoma. AM Di Bisceglie, Hepatology 1997 26 3 suppl 1 34S 38S 10.1002/hep.510260706 9305661 (Pubitemid 27388069)
2. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. G Fattovich T Stroffolini I Zagni F Donato, Gastroenterology 2004 127 35 S50 10.1053/j.gastro.2004.09.014 15508101
3. Tutorial in biostatistics: competing risks and multi-state models. H Putter M Fiocco RB Geskus, Statistics in Medicine 2007 26 2389 2430 10.1002/sim.2712 17031868 (Pubitemid 46730255)
4. Considerations on a staging process for chronic diseases. G Serio A Morabito, Rivista di Statistica Applicata 1988 21 23 335 348
5. Stochastic survival model with covariates in cancer. G Serio A Morabito, Modelling of Biomedical Systems 1986 91 96
6. A Markov chain method to estimate the tumour progression rate from preclinical to clinical phase, sensitivity and positive predictive value for mammography in breast cancer screening. HH Chen SW Duffy L Tabar, The Statistician 1996 45 3 307 317 10.2307/2988469 (Pubitemid 126421009)
7. Hidden Markov models for the onset and progression of bronchiolitis obliterans syndrome in lung transplant recipients. CH Jackson LD Sharples, Statistics in Medicine 2002 21 113 128 10.1002/sim.886 11782054 (Pubitemid 34065708)
8. Latent class models: recent developments and prospects for the future. CC Clogg, Handbook of Statistical Modeling in the Social Sciences Plenum, New York, Arminger G, Clogg CC, Sobel ME, 1995 311 359
9. Hidden Markov Models and Other Models for Discrete-valued Time Series. IL MacDonald W Zucchini, Chapman and Hall: New York 1997
10. Direct Modelling of Regression Effects for Transition Probabilities in Multistate Models. TH Scheike M Zhang, Scandinavian Journal of Statistics 2007 34 17 32 10.1111/j.1467-9469.2006.00544.x
11. Regression Models and Life-Tables. D Cox, Journal of the Royal Statistical Society, Series B 1972 34 187 220
12. Multistate Markov models for disease progression with classification error. CH Jackson LD Sharples SG Thompson SW Duffy E Couto, Journal of the Royal Statistical Society, Series D - The Statistician 2003 52 2 193 209 10.1111/1467-9884.00351 (Pubitemid 37268398)
13. Applications of continuous time hidden Markov models to the study of misclassified disease outcomes. A Bureau S Shiboski JP Hughes, Statistics in Medicine 2003 22 441 462 10.1002/sim.1270 12529874 (Pubitemid 36163597)
14. The analysis of panel data under a Markov assumption. JD Kalbfleisch JF Lawless, Journal of the American Statistical Association 1985 80 392 863 871 10.2307/2288545
15. A Markov model for analysing cancer markers and disease states in survival studies. R Kay, Biometrics 1986 42 855 865 10.2307/2530699 2434150 (Pubitemid 17134904)
16. The Theory of Stochastic Processes. DR Cox HD Miller, Chapman and Hall, London 1965
17. Proportional Hazards Tests and Diagnostics Based on Weighted Residuals. P Grambsch T Therneau, Biometrika 1994 81 515 26 10.1093/biomet/81.3.515
18. Chi-squared goodness of fit test for the proportional hazards regression model. D Schoenfeld, Biometrika 1981 67 147 53
19. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. ME Charlson P Pompei KL Ales CR MacKenzie, J Chron Dis 1987 40 373 383 10.1016/0021-9681(87)90171-8 3558716 (Pubitemid 17055592)
20. Adapting a clinical comorbidity index for use with ICD-9- CM administrative databases. RA Deyo DC Cherkin MA Ciol, J Clin Epidemiol 1992 45 613 619 10.1016/0895-4356(92)90133-8 1607900
21. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. SD Ryder, Gut 2003 52 Suppl. III ii1 8 12692148
22. Hepatic Carcinoma, Primary Author: Keith E Stuart, MD, Chairman, Department of Hematology and Oncology, Lahey Clinic Coauthor(s): Zsofia K Stadler, MD. http://emedicine.medscape.com/article/282814-overview
23. Estimation of mean sojourn time in breast cancer screening using a Markov chain model of entry to and exit from preclinical detectable phase. SW Duffy HH Chen, Statistics in Medicine 1995 14 1531 1543 10.1002/sim.4780141404 7481190
24. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. SN Zaman WM Melia RD Johnson BC Portmann PJ Johnson R Williams, Lancet 1985 1 1357 60 10.1016/S0140-6736(85)91785-4 2861313 (Pubitemid 15060907)
25. Risk factors for hepatocellular carcinoma in patients with cirrhosis. SA Sarbah T Gramlich A Younoszai, et al. Dig Dis Sci 2004 49 850 853 10.1023/B:DDAS.0000030098.75759.32 15259508 (Pubitemid 38870213)
26. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. F Degos C Christidis N Ganne-Carrie JP Farmachidi C Degott C Guettier JC Trinchet M Beaugrand S Chevret, Gut 2000 47 131 136 10.1136/gut.47.1.131 10861275 (Pubitemid 30430422)
27. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. GN Ioannou MF Splan NS Weiss GB McDonald L Beretta SP Lee, Clin Gastroenterol Hepatol 2007 5 938 945 945.e1-945.e4 10.1016/j.cgh.2007.02.039 17509946
28. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. G Fattovich G Giustina F Degos, et al. Gastroenterology 1997 112 463 472 10.1053/gast.1997.v112.pm9024300 9024300 (Pubitemid 27078833)
29. Hepatocellular carcinoma in Italian patients with cirrhosis. M Colombo R de Franchis E Del Ninno, et al. N Engl J Med 1991 325 675 680 10.1056/NEJM199109053251002 1651452
30. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. G N'Kontchou J Paries MT Htar, et al. Clin Gastroenterol Hepatol 2006 4 1062 1068 16844421 (Pubitemid 44137435)
31. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. A Sangiovanni E Del Ninno P Fasani C De Fazio G Ronchi R Romeo A Morabito R de Franchis M Colombo, Gastroenterology 2004 126 1005 1014 10.1053/j.gastro.2003.12.049 15057740 (Pubitemid 38451172)
32. Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis. L Benvegn L Chemello F Noventa G Fattovich P Pontisso A Alberti, Cancer 1998 83 901 909 9731893 (Pubitemid 28401923)
33. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. L Bolondi S Sofia S Siringo S Gaiani A Casali G Zironi F Piscaglia L Gramantieri M Zanetti M Sherman, Gut 2001 48 251 259 10.1136/gut.48.2.251 11156649 (Pubitemid 32141852)
34. Diabetes mellitus and the risk of primary liver cancer. C La Vecchia E Negri A Decarli, et al. Int J Cancer 1997 73 204 207 10.1002/(SICI)1097- 0215(19971009)73:2<204::AID-IJC7>3.0.CO;2-# 9335443 (Pubitemid 27448819)
35. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. HB El-Serag T Tran JE Everhart, Gastroenterology 2004 126 460 468 10.1053/j.gastro.2003.10.065 14762783 (Pubitemid 38182303)
36. Liver cancer. WT London KA McGlynn, Cancer Epidemiology and Prevention New York: Oxford University Press, Schottenfeld D, Fraumeni JF Jr, 1996 772 93
37. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case -control study of 213 hepatocellular carcinoma patients from India. M Kumar R Kumar SS Hissar MK Saraswat BC Sharma P Sakhuja SK Sarin, J Gastroenterol Hepatol 2007 22 7 1104 11 10.1111/j.1440-1746.2007. 04908.x 17559381 (Pubitemid 47019860)
38. Progression to cirrhosis in hepatitis C patients: an age-dependent process. P Pradat N Voirin HL Tillmann M Chevallier C Trepo, Liver Int 2007 27 3 335 339 10.1111/j.1478-3231.2006.01430.x 17355454 (Pubitemid 46416623)
39. Statistical estimation of parameters in a disease transmission model: analysis of a Cryptosporidium outbreak. MA Brookhart AE Hubbard MJ Van Der Laan JM Colford Jr JN Eisenberg, Statistics in Medicine 2002 21 3627 38 10.1002/sim.1258 12436460 (Pubitemid 35363545)
40. The analysis of hospital infection data using hidden Markov models. B Cooper M Lipsitch, Biostatistics 2004 5 2 223 237 10.1093/biostatistics/5.2.223 15054027 (Pubitemid 41180225)